Skip to main content
. Author manuscript; available in PMC: 2016 Feb 26.
Published in final edited form as: Bone Marrow Transplant. 2014 Jun 2;49(8):1029–1035. doi: 10.1038/bmt.2014.116

Figure 2.

Figure 2

Survival after Relapse by Treatment Type

Survival over the first year following relapse was higher in patients receiving intensive treatment (p < 0.01). At one year, OS was 37% following intensive therapy and 11% following supportive care. Of note, patients who were managed at other centers at the time of relapse and whose treatment could not be determined did worse than the known supportive care group.